Joseph Mrus

Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression

Susan Swindells, Jaime Andrade‐Villanueva, Gary Richmond et al. · New England Journal of Medicine · 2020 · 523 citations · Full text

Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial

David A. Margolis, Juan González‐García, Hans-Jürgen Stellbrink et al. · The Lancet · 2017 · 492 citations

Treatment And Prevention, Medicine, Phase 2B +8

Spirituality and religion in patients with HIV/AIDS

Sian Cotton, Christina M. Puchalski, Susan N. Sherman et al. · Journal of General Internal Medicine · 2006 · 354 citations · Full text

Religiosity, Christian Practice, Spirituality +3

Gender differences in health-related quality of life in patients with HIV/AIDS

Joseph Mrus, Paige L. Williams, Joel Tsevat et al. · Quality of Life Research · 2005 · 165 citations

Quality Of Life, Sexual Health, Life Satisfaction +10

Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials

Giuliano Rizzardini, Edgar T. Overton, Chloe Orkin et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2020 · 137 citations · Full text